OrthoSens SA

Orthopedic surgeries still rely on static X-rays and sporadic follow-ups, providing minimal real-time feedback. Surgeons often depend on subjective patient reports, risking delayed interventions, reoperations, and suboptimal outcomes.

OrthoSens solves this by embedding its battery-free Sens+ sensor into implants. SensApp transforms real-time implant data into a recovery movie, enabling timely decisions and better engagement. Led by CEO Gwenael Hannema, R&D lead Dr. Oleg Kotsur, advisor & board member Philippe Etter, Kelly Carroll and Prof. Alex Alfieri (KSW Neurosurgery Chairman), OrthoSens merges deep medtech, sensor, and clinical expertise. Targeting a global $56B orthopedic market & $5.9B remote patient monitoring, they aim to redefine post-surgical care.